Wonder vigilance.

Suppr

超能文献

作者信息

Edwards I Ralph

机构信息

Uppsala Monitoring Centre, Uppsala S-75320, Sweden.

出版信息

Drug Saf. 2010 Feb 1;33(2):83-6. doi: 10.2165/11532300-000000000-00000.

DOI:10.2165/11532300-000000000-00000

PMID:20088622

Abstract

摘要

相似文献

Wonder vigilance.

Drug Saf. 2010 Feb 1;33(2):83-6. doi: 10.2165/11532300-000000000-00000.

[Drug safety: from development to clinical use].

Antibiot Khimioter. 2006;51(6):15-22.

Pharmacovigilance: Importance, concepts, and processes.

Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24.

Monitoring drug product quality.

Am Pharm. 1992 Feb;NS32(2):47-9. doi: 10.1016/s0160-3450(15)31213-7.

[Safety of medicinal products and reporting of adverse drug reactions].

Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Monitoring and managing adverse drug reactions.

Am Pharm. 1992 Feb;NS32(2):74-81. doi: 10.1016/s0160-3450(15)31215-0.

Medicine Safety Monitoring in Pediatric Population in India.

Indian J Pediatr. 2016 May;83(5):479-80. doi: 10.1007/s12098-015-1931-z. Epub 2015 Dec 4.

Pharmacovigilance activities in Nepal.

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

Modern methods of pharmacovigilance: detecting adverse effects of drugs.

Clin Med (Lond). 2009 Oct;9(5):486-9. doi: 10.7861/clinmedicine.9-5-486.

本文引用的文献

Observational research, randomised trials, and two views of medical science.

PLoS Med. 2008 Mar 11;5(3):e67. doi: 10.1371/journal.pmed.0050067.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Wonder vigilance.

Drug Saf. 2010 Feb 1;33(2):83-6. doi: 10.2165/11532300-000000000-00000.

[Drug safety: from development to clinical use].

Antibiot Khimioter. 2006;51(6):15-22.

Pharmacovigilance: Importance, concepts, and processes.

Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24.

Monitoring drug product quality.

Am Pharm. 1992 Feb;NS32(2):47-9. doi: 10.1016/s0160-3450(15)31213-7.

[Safety of medicinal products and reporting of adverse drug reactions].

Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Monitoring and managing adverse drug reactions.

Am Pharm. 1992 Feb;NS32(2):74-81. doi: 10.1016/s0160-3450(15)31215-0.

Medicine Safety Monitoring in Pediatric Population in India.

Indian J Pediatr. 2016 May;83(5):479-80. doi: 10.1007/s12098-015-1931-z. Epub 2015 Dec 4.

Pharmacovigilance activities in Nepal.

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

Modern methods of pharmacovigilance: detecting adverse effects of drugs.

Clin Med (Lond). 2009 Oct;9(5):486-9. doi: 10.7861/clinmedicine.9-5-486.

本文引用的文献

Observational research, randomised trials, and two views of medical science.

PLoS Med. 2008 Mar 11;5(3):e67. doi: 10.1371/journal.pmed.0050067.